Insiders · Profile

Baldry Mark

Chief Commercial Officer at X4 Pharmaceuticals. Filing since 1 Nov 2023. CIK 0001644137

Company
Date
Role
Action
Shares
Amount
Of holding
16 May 2025
Chief Commercial Officer
Bought
1,032
$2.56K
4.2%
24 Jan 2025
Chief Commercial Officer
Sold at will
29,159
$13.24K
23.7%
15 Nov 2024
Chief Commercial Officer
Bought
13,404
$4.60K
11.6%
7 Oct 2024
Chief Commercial Officer
Sold at will
11,127
$6.51K
18.7%
17 May 2024
Chief Commercial Officer
Bought
21,646
$14.65K
23.0%
1 Nov 2023
Chief Commercial Officer
Sold on a plan
10,257
$7.49K
29.4%
6 decisions on file.